Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro

被引:66
作者
Ekong, TAN [1 ]
Feavers, IM [1 ]
Sesardic, D [1 ]
机构
[1] NATL INST BIOL STAND & CONTROLS, DIV BACTERIOL, POTTERS BAR EN6 3QG, HERTS, ENGLAND
来源
MICROBIOLOGY-SGM | 1997年 / 143卷
关键词
botulinum neurotoxin type A; endopeptidase assay; recombinant SNAP-25; targeted antibodies;
D O I
10.1099/00221287-143-10-3337
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial neurotoxins are now being used routinely for the treatment of neuromuscular conditions. Alternative assays to replace or to complement in vivo bioassay methods for assessment of the safety and potency of these botulinum neurotoxin-based therapeutic products are urgently needed. Advances made in understanding the mode of action of clostridial neurotoxins have provided the basis for the development of alternative mechanism-based assay methods, Thus, the identification of SNAP-25 (synaptosomal-associated protein of molecular mass 25 kDa) as the intracellular protein target which is selectively cleaved during poisoning by botulinum neurotoxin type A (BoNT/A) has enabled the development of a functional in vitro assay for this toxin. Using recombinant DNA methods, a segment of SNAP-25 (aa residues 134-206) spanning the toxin cleavage site was prepared as a fusion protein to the maltose-binding protein in Escherichia coli. The fusion protein was purified by affinity chromatography and the fragment isolated after cleavage with Factor Xa, Targeted antibodies specific for the N and C termini of SNAP-25, as well as the toxin cleavage site, were prepared and used in an immunoassay to demonstrate BoNT/A endopeptidase activity towards recombinant SNAP-25 substrates. The reaction required low concentrations of reducing agents which were inhibitory at higher concentrations as were metal chelators and some inhibitors of metallopeptidases, The endopeptidase assay has proved to be more sensitive than the mouse bioassay for detection of toxin in therapeutic preparations, A good correlation with results obtained in the in vivo bioassay (r = 0.95, n = 23) was demonstrated, The endopeptidase assay described here may provide a suitable replacement assay for the estimation of the potency of type A toxin in therapeutic preparations.
引用
收藏
页码:3337 / 3347
页数:11
相关论文
共 41 条
  • [1] BALLS M, 1996, DEV BIOL STAND, V86, P8
  • [2] BINZ T, 1994, J BIOL CHEM, V269, P1617
  • [3] BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25
    BLASI, J
    CHAPMAN, ER
    LINK, E
    BINZ, T
    YAMASAKI, S
    DECAMILLI, P
    SUDHOF, TC
    NIEMANN, H
    JAHN, R
    [J]. NATURE, 1993, 365 (6442) : 160 - 163
  • [4] SENSITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR DETECTION OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN-A, NEUROTOXIN-B, AND NEUROTOXIN-E USING SIGNAL AMPLIFICATION VIA ENZYME-LINKED COAGULATION ASSAY
    DOELLGAST, GJ
    TRISCOTT, MX
    BEARD, GA
    BOTTOMS, JD
    CHENG, T
    ROH, BH
    ROMAN, MG
    HALL, PA
    BROWN, JE
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) : 2402 - 2409
  • [5] Ekong T, 1997, DEV AN VET, V27, P1039
  • [6] IMMUNOLOGICAL DETECTION OF CLOSTRIDIUM-BOTULINUM TOXIN TYPE-A IN THERAPEUTIC PREPARATIONS
    EKONG, TAN
    MCLELLAN, K
    SESARDIC, D
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 180 (02) : 181 - 191
  • [7] Tyrosine phosphorylation modulates the activity of clostridial neurotoxins
    FerrerMontiel, AV
    Canaves, JM
    DasGupta, BR
    Wilson, MC
    Montal, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) : 18322 - 18325
  • [8] Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release
    Foran, P
    Lawrence, GW
    Shone, CC
    Foster, KA
    Dolly, JO
    [J]. BIOCHEMISTRY, 1996, 35 (08) : 2630 - 2636
  • [9] DIFFERENCES IN THE PROTEASE ACTIVITIES OF TETANUS AND BOTULINUM-B TOXINS REVEALED BY THE CLEAVAGE OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN AND VARIOUS SIZED FRAGMENTS
    FORAN, P
    SHONE, CC
    DOLLY, JO
    [J]. BIOCHEMISTRY, 1994, 33 (51) : 15365 - 15374
  • [10] EXPRESSION OF BIOLOGICALLY-ACTIVE C3A AS FUSION PROTEINS
    FUKUOKA, Y
    TACHIBANA, T
    YASUI, A
    [J]. IMMUNOLOGY LETTERS, 1993, 38 (02) : 153 - 158